APO Research
Talk to an analyst

APO RESEARCH · REPORT

Congestive Heart Failure Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Congestive Heart Failure Drugs Industry Research Report 2026

27 December 2025145 pages

Choose your research edition.

Industry ResearchCongestive Heart Failure Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Congestive Heart Failure Drugs Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Congestive Heart Failure Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Congestive Heart Failure Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Congestive Heart Failure Drugs Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Congestive Heart Failure Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Congestive Heart Failure Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Congestive Heart Failure Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Congestive Heart Failure Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Congestive Heart Failure Drugs include Sanofi, Johnson & Johnson, Novartis, Merck & Co, Mylan, Pfizer, GSK, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Congestive Heart Failure Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Congestive Heart Failure Drugs Market by Company

Sanofi

Johnson & Johnson

Novartis

Merck & Co

Mylan

Pfizer

GSK

Bayer

AstraZeneca

Xudong Haipu Pharmaceutical

Xinhua Group

Sinepharm

NCPC

Lunan Pharmaceutical

Langtian

Hayao

Hai Ni Pharmaceutical

Exelixis

CRC

Bristol-Myers Squibb

Boehringer Inhelheim

Bausch Health

Congestive Heart Failure Drugs Segment by Type

Capsule

Tablets

Injection

Congestive Heart Failure Drugs Segment by Application

Clinic

Hospital

Household

Other

Congestive Heart Failure Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Congestive Heart Failure Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Congestive Heart Failure Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Congestive Heart Failure Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Congestive Heart Failure Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Congestive Heart Failure Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Congestive Heart Failure Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Congestive Heart Failure Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Congestive Heart Failure Drugs Sales (K Tons) of Manufacturers (2021-2026) Table 7. Global Congestive Heart Failure Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Congestive Heart Failure Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Congestive Heart Failure Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Congestive Heart Failure Drugs Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global Congestive Heart Failure Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Congestive Heart Failure Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Congestive Heart Failure Drugs, Product Type & Application Table 14. Global Congestive Heart Failure Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Congestive Heart Failure Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sanofi Company Information Table 19. Sanofi Business Overview Table 20. Sanofi Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. Sanofi Congestive Heart Failure Drugs Product Portfolio Table 22. Sanofi Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. Johnson & Johnson Congestive Heart Failure Drugs Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Novartis Company Information Table 29. Novartis Business Overview Table 30. Novartis Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. Novartis Congestive Heart Failure Drugs Product Portfolio Table 32. Novartis Recent Developments Table 33. Merck & Co Company Information Table 34. Merck & Co Business Overview Table 35. Merck & Co Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Merck & Co Congestive Heart Failure Drugs Product Portfolio Table 37. Merck & Co Recent Developments Table 38. Mylan Company Information Table 39. Mylan Business Overview Table 40. Mylan Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. Mylan Congestive Heart Failure Drugs Product Portfolio Table 42. Mylan Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Pfizer Congestive Heart Failure Drugs Product Portfolio Table 47. Pfizer Recent Developments Table 48. GSK Company Information Table 49. GSK Business Overview Table 50. GSK Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. GSK Congestive Heart Failure Drugs Product Portfolio Table 52. GSK Recent Developments Table 53. Bayer Company Information Table 54. Bayer Business Overview Table 55. Bayer Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Bayer Congestive Heart Failure Drugs Product Portfolio Table 57. Bayer Recent Developments Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. AstraZeneca Congestive Heart Failure Drugs Product Portfolio Table 62. AstraZeneca Recent Developments Table 63. Xudong Haipu Pharmaceutical Company Information Table 64. Xudong Haipu Pharmaceutical Business Overview Table 65. Xudong Haipu Pharmaceutical Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Xudong Haipu Pharmaceutical Congestive Heart Failure Drugs Product Portfolio Table 67. Xudong Haipu Pharmaceutical Recent Developments Table 68. Xinhua Group Company Information Table 69. Xinhua Group Business Overview Table 70. Xinhua Group Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Xinhua Group Congestive Heart Failure Drugs Product Portfolio Table 72. Xinhua Group Recent Developments Table 73. Sinepharm Company Information Table 74. Sinepharm Business Overview Table 75. Sinepharm Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Sinepharm Congestive Heart Failure Drugs Product Portfolio Table 77. Sinepharm Recent Developments Table 78. NCPC Company Information Table 79. NCPC Business Overview Table 80. NCPC Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. NCPC Congestive Heart Failure Drugs Product Portfolio Table 82. NCPC Recent Developments Table 83. Lunan Pharmaceutical Company Information Table 84. Lunan Pharmaceutical Business Overview Table 85. Lunan Pharmaceutical Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Lunan Pharmaceutical Congestive Heart Failure Drugs Product Portfolio Table 87. Lunan Pharmaceutical Recent Developments Table 88. Langtian Company Information Table 89. Langtian Business Overview Table 90. Langtian Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Langtian Congestive Heart Failure Drugs Product Portfolio Table 92. Langtian Recent Developments Table 93. Hayao Company Information Table 94. Hayao Business Overview Table 95. Hayao Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Hayao Congestive Heart Failure Drugs Product Portfolio Table 97. Hayao Recent Developments Table 98. Hai Ni Pharmaceutical Company Information Table 99. Hai Ni Pharmaceutical Business Overview Table 100. Hai Ni Pharmaceutical Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Hai Ni Pharmaceutical Congestive Heart Failure Drugs Product Portfolio Table 102. Hai Ni Pharmaceutical Recent Developments Table 103. Exelixis Company Information Table 104. Exelixis Business Overview Table 105. Exelixis Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Exelixis Congestive Heart Failure Drugs Product Portfolio Table 107. Exelixis Recent Developments Table 108. CRC Company Information Table 109. CRC Business Overview Table 110. CRC Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. CRC Congestive Heart Failure Drugs Product Portfolio Table 112. CRC Recent Developments Table 113. Bristol-Myers Squibb Company Information Table 114. Bristol-Myers Squibb Business Overview Table 115. Bristol-Myers Squibb Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Bristol-Myers Squibb Congestive Heart Failure Drugs Product Portfolio Table 117. Bristol-Myers Squibb Recent Developments Table 118. Boehringer Inhelheim Company Information Table 119. Boehringer Inhelheim Business Overview Table 120. Boehringer Inhelheim Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Boehringer Inhelheim Congestive Heart Failure Drugs Product Portfolio Table 122. Boehringer Inhelheim Recent Developments Table 123. Bausch Health Company Information Table 124. Bausch Health Business Overview Table 125. Bausch Health Congestive Heart Failure Drugs Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Bausch Health Congestive Heart Failure Drugs Product Portfolio Table 127. Bausch Health Recent Developments Table 128. Global Congestive Heart Failure Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 129. Global Congestive Heart Failure Drugs Sales by Region (2021-2026) & (K Tons) Table 130. Global Congestive Heart Failure Drugs Sales Market Share by Region (2021-2026) Table 131. Global Congestive Heart Failure Drugs Sales by Region (2027-2032) & (K Tons) Table 132. Global Congestive Heart Failure Drugs Sales Market Share by Region (2027-2032) Table 133. Global Congestive Heart Failure Drugs Revenue by Region (2021-2026) & (US$ Million) Table 134. Global Congestive Heart Failure Drugs Revenue Market Share by Region (2021-2026) Table 135. Global Congestive Heart Failure Drugs Revenue by Region (2027-2032) & (US$ Million) Table 136. Global Congestive Heart Failure Drugs Revenue Market Share by Region (2027-2032) Table 137. North America Congestive Heart Failure Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. North America Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 139. North America Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 140. North America Congestive Heart Failure Drugs Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Congestive Heart Failure Drugs Revenue by Country (2027-2032) & (US$ Million) Table 142. Europe Congestive Heart Failure Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Europe Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 144. Europe Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 145. Europe Congestive Heart Failure Drugs Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Congestive Heart Failure Drugs Revenue by Country (2027-2032) & (US$ Million) Table 147. Asia Pacific Congestive Heart Failure Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Asia Pacific Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 149. Asia Pacific Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 150. Asia Pacific Congestive Heart Failure Drugs Revenue by Country (2021-2026) & (US$ Million) Table 151. Asia Pacific Congestive Heart Failure Drugs Revenue by Country (2027-2032) & (US$ Million) Table 152. South America Congestive Heart Failure Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. South America Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 154. South America Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 155. South America Congestive Heart Failure Drugs Revenue by Country (2021-2026) & (US$ Million) Table 156. South America Congestive Heart Failure Drugs Revenue by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Congestive Heart Failure Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Middle East and Africa Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 159. Middle East and Africa Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 160. Middle East and Africa Congestive Heart Failure Drugs Revenue by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Congestive Heart Failure Drugs Revenue by Country (2027-2032) & (US$ Million) Table 162. Global Congestive Heart Failure Drugs Sales by Type (2021-2026) & (K Tons) Table 163. Global Congestive Heart Failure Drugs Sales by Type (2027-2032) & (K Tons) Table 164. Global Congestive Heart Failure Drugs Sales Market Share by Type (2021-2026) Table 165. Global Congestive Heart Failure Drugs Sales Market Share by Type (2027-2032) Table 166. Global Congestive Heart Failure Drugs Revenue by Type (2021-2026) & (US$ Million) Table 167. Global Congestive Heart Failure Drugs Revenue by Type (2027-2032) & (US$ Million) Table 168. Global Congestive Heart Failure Drugs Revenue Market Share by Type (2021-2026) Table 169. Global Congestive Heart Failure Drugs Revenue Market Share by Type (2027-2032) Table 170. Global Congestive Heart Failure Drugs Price by Type (2021-2026) & (US$/Ton) Table 171. Global Congestive Heart Failure Drugs Price by Type (2027-2032) & (US$/Ton) Table 172. Global Congestive Heart Failure Drugs Sales by Application (2021-2026) & (K Tons) Table 173. Global Congestive Heart Failure Drugs Sales by Application (2027-2032) & (K Tons) Table 174. Global Congestive Heart Failure Drugs Sales Market Share by Application (2021-2026) Table 175. Global Congestive Heart Failure Drugs Sales Market Share by Application (2027-2032) Table 176. Global Congestive Heart Failure Drugs Revenue by Application (2021-2026) & (US$ Million) Table 177. Global Congestive Heart Failure Drugs Revenue by Application (2027-2032) & (US$ Million) Table 178. Global Congestive Heart Failure Drugs Revenue Market Share by Application (2021-2026) Table 179. Global Congestive Heart Failure Drugs Revenue Market Share by Application (2027-2032) Table 180. Global Congestive Heart Failure Drugs Price by Application (2021-2026) & (US$/Ton) Table 181. Global Congestive Heart Failure Drugs Price by Application (2027-2032) & (US$/Ton) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Congestive Heart Failure Drugs Distributors List Table 185. Congestive Heart Failure Drugs Customers List Table 186. Congestive Heart Failure Drugs Industry Trends Table 187. Congestive Heart Failure Drugs Industry Drivers Table 188. Congestive Heart Failure Drugs Industry Restraints Table 189. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Congestive Heart Failure Drugs Product Image Figure 5. Global Congestive Heart Failure Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Congestive Heart Failure Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Congestive Heart Failure Drugs Sales (2021-2032) & (K Tons) Figure 8. Global Congestive Heart Failure Drugs Average Price (US$/Ton) & (2021-2032) Figure 9. Capsule Product Image Figure 10. Tablets Product Image Figure 11. Injection Product Image Figure 12. Clinic Product Image Figure 13. Hospital Product Image Figure 14. Household Product Image Figure 15. Other Product Image Figure 16. Global Congestive Heart Failure Drugs Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Congestive Heart Failure Drugs, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Congestive Heart Failure Drugs Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Congestive Heart Failure Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Congestive Heart Failure Drugs Sales by Region in 2025 Figure 22. Global Congestive Heart Failure Drugs Revenue by Region in 2025 Figure 23. North America Congestive Heart Failure Drugs Market Size by Country in 2025 Figure 24. North America Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 25. North America Congestive Heart Failure Drugs Revenue Market Share by Country (2021-2032) Figure 26. United States Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Congestive Heart Failure Drugs Market Size by Country in 2025 Figure 30. Europe Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 31. Europe Congestive Heart Failure Drugs Revenue Market Share by Country (2021-2032) Figure 32. Germany Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Congestive Heart Failure Drugs Market Size by Country in 2025 Figure 43. Asia Pacific Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Congestive Heart Failure Drugs Revenue Market Share by Country (2021-2032) Figure 45. China Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Congestive Heart Failure Drugs Market Size by Country in 2025 Figure 54. South America Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 55. South America Congestive Heart Failure Drugs Revenue Market Share by Country (2021-2032) Figure 56. Brazil Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Congestive Heart Failure Drugs Market Size by Country in 2025 Figure 60. Middle East and Africa Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Congestive Heart Failure Drugs Revenue Market Share by Country (2021-2032) Figure 62. Egypt Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Congestive Heart Failure Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Congestive Heart Failure Drugs Sales Market Share by Type (2021-2032) Figure 68. Global Congestive Heart Failure Drugs Revenue Market Share by Type (2021-2032) Figure 69. Global Congestive Heart Failure Drugs Price (US$/Ton) by Type (2021-2032) Figure 70. Global Congestive Heart Failure Drugs Sales Market Share by Application (2021-2032) Figure 71. Global Congestive Heart Failure Drugs Revenue Market Share by Application (2021-2032) Figure 72. Global Congestive Heart Failure Drugs Price (US$/Ton) by Application (2021-2032) Figure 73. Congestive Heart Failure Drugs Value Chain Figure 74. Congestive Heart Failure Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Congestive Heart Failure Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Capsule
  • Tablets
  • Injection
Applications
  • Clinic
  • Hospital
  • Household
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co
  • Mylan
  • Pfizer
  • GSK
  • Bayer
  • AstraZeneca
  • Xudong Haipu Pharmaceutical
  • Xinhua Group
  • Sinepharm
  • NCPC
  • Lunan Pharmaceutical
  • Langtian
  • Hayao
  • Hai Ni Pharmaceutical
  • Exelixis
  • CRC
  • Bristol-Myers Squibb
  • Boehringer Inhelheim
  • Bausch Health

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Congestive Heart Failure Drugs Market Size (2021-2032)
  4. 2.2.2 Global Congestive Heart Failure Drugs Sales (2021-2032)
  5. 2.2.3 Global Congestive Heart Failure Drugs Market Average Price (2021-2032)
  6. 2.3 Congestive Heart Failure Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Capsule
  9. 2.3.3 Tablets
  10. 2.3.4 Injection
  11. 2.4 Congestive Heart Failure Drugs by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Clinic
  14. 2.4.3 Hospital
  15. 2.4.4 Household
  16. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Congestive Heart Failure Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Congestive Heart Failure Drugs Sales (K Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Congestive Heart Failure Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Congestive Heart Failure Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Congestive Heart Failure Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Congestive Heart Failure Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Congestive Heart Failure Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Congestive Heart Failure Drugs, Established Date
  9. 3.9 Global Congestive Heart Failure Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sanofi
  2. 4.1.1 Sanofi Company Information
  3. 4.1.2 Sanofi Business Overview
  4. 4.1.3 Sanofi Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sanofi Congestive Heart Failure Drugs Product Portfolio
  6. 4.1.5 Sanofi Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson Congestive Heart Failure Drugs Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Novartis
  14. 4.3.1 Novartis Company Information
  15. 4.3.2 Novartis Business Overview
  16. 4.3.3 Novartis Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novartis Congestive Heart Failure Drugs Product Portfolio
  18. 4.3.5 Novartis Recent Developments
  19. 4.4 Merck & Co
  20. 4.4.1 Merck & Co Company Information
  21. 4.4.2 Merck & Co Business Overview
  22. 4.4.3 Merck & Co Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Merck & Co Congestive Heart Failure Drugs Product Portfolio
  24. 4.4.5 Merck & Co Recent Developments
  25. 4.5 Mylan
  26. 4.5.1 Mylan Company Information
  27. 4.5.2 Mylan Business Overview
  28. 4.5.3 Mylan Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Mylan Congestive Heart Failure Drugs Product Portfolio
  30. 4.5.5 Mylan Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer Congestive Heart Failure Drugs Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 GSK
  38. 4.7.1 GSK Company Information
  39. 4.7.2 GSK Business Overview
  40. 4.7.3 GSK Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 GSK Congestive Heart Failure Drugs Product Portfolio
  42. 4.7.5 GSK Recent Developments
  43. 4.8 Bayer
  44. 4.8.1 Bayer Company Information
  45. 4.8.2 Bayer Business Overview
  46. 4.8.3 Bayer Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Bayer Congestive Heart Failure Drugs Product Portfolio
  48. 4.8.5 Bayer Recent Developments
  49. 4.9 AstraZeneca
  50. 4.9.1 AstraZeneca Company Information
  51. 4.9.2 AstraZeneca Business Overview
  52. 4.9.3 AstraZeneca Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 AstraZeneca Congestive Heart Failure Drugs Product Portfolio
  54. 4.9.5 AstraZeneca Recent Developments
  55. 4.10 Xudong Haipu Pharmaceutical
  56. 4.10.1 Xudong Haipu Pharmaceutical Company Information
  57. 4.10.2 Xudong Haipu Pharmaceutical Business Overview
  58. 4.10.3 Xudong Haipu Pharmaceutical Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Xudong Haipu Pharmaceutical Congestive Heart Failure Drugs Product Portfolio
  60. 4.10.5 Xudong Haipu Pharmaceutical Recent Developments
  61. 4.11 Xinhua Group
  62. 4.11.1 Xinhua Group Company Information
  63. 4.11.2 Xinhua Group Business Overview
  64. 4.11.3 Xinhua Group Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Xinhua Group Congestive Heart Failure Drugs Product Portfolio
  66. 4.11.5 Xinhua Group Recent Developments
  67. 4.12 Sinepharm
  68. 4.12.1 Sinepharm Company Information
  69. 4.12.2 Sinepharm Business Overview
  70. 4.12.3 Sinepharm Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sinepharm Congestive Heart Failure Drugs Product Portfolio
  72. 4.12.5 Sinepharm Recent Developments
  73. 4.13 NCPC
  74. 4.13.1 NCPC Company Information
  75. 4.13.2 NCPC Business Overview
  76. 4.13.3 NCPC Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 NCPC Congestive Heart Failure Drugs Product Portfolio
  78. 4.13.5 NCPC Recent Developments
  79. 4.14 Lunan Pharmaceutical
  80. 4.14.1 Lunan Pharmaceutical Company Information
  81. 4.14.2 Lunan Pharmaceutical Business Overview
  82. 4.14.3 Lunan Pharmaceutical Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Lunan Pharmaceutical Congestive Heart Failure Drugs Product Portfolio
  84. 4.14.5 Lunan Pharmaceutical Recent Developments
  85. 4.15 Langtian
  86. 4.15.1 Langtian Company Information
  87. 4.15.2 Langtian Business Overview
  88. 4.15.3 Langtian Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Langtian Congestive Heart Failure Drugs Product Portfolio
  90. 4.15.5 Langtian Recent Developments
  91. 4.16 Hayao
  92. 4.16.1 Hayao Company Information
  93. 4.16.2 Hayao Business Overview
  94. 4.16.3 Hayao Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Hayao Congestive Heart Failure Drugs Product Portfolio
  96. 4.16.5 Hayao Recent Developments
  97. 4.17 Hai Ni Pharmaceutical
  98. 4.17.1 Hai Ni Pharmaceutical Company Information
  99. 4.17.2 Hai Ni Pharmaceutical Business Overview
  100. 4.17.3 Hai Ni Pharmaceutical Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hai Ni Pharmaceutical Congestive Heart Failure Drugs Product Portfolio
  102. 4.17.5 Hai Ni Pharmaceutical Recent Developments
  103. 4.18 Exelixis
  104. 4.18.1 Exelixis Company Information
  105. 4.18.2 Exelixis Business Overview
  106. 4.18.3 Exelixis Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Exelixis Congestive Heart Failure Drugs Product Portfolio
  108. 4.18.5 Exelixis Recent Developments
  109. 4.19 CRC
  110. 4.19.1 CRC Company Information
  111. 4.19.2 CRC Business Overview
  112. 4.19.3 CRC Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 CRC Congestive Heart Failure Drugs Product Portfolio
  114. 4.19.5 CRC Recent Developments
  115. 4.20 Bristol-Myers Squibb
  116. 4.20.1 Bristol-Myers Squibb Company Information
  117. 4.20.2 Bristol-Myers Squibb Business Overview
  118. 4.20.3 Bristol-Myers Squibb Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Bristol-Myers Squibb Congestive Heart Failure Drugs Product Portfolio
  120. 4.20.5 Bristol-Myers Squibb Recent Developments
  121. 4.21 Boehringer Inhelheim
  122. 4.21.1 Boehringer Inhelheim Company Information
  123. 4.21.2 Boehringer Inhelheim Business Overview
  124. 4.21.3 Boehringer Inhelheim Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Boehringer Inhelheim Congestive Heart Failure Drugs Product Portfolio
  126. 4.21.5 Boehringer Inhelheim Recent Developments
  127. 4.22 Bausch Health
  128. 4.22.1 Bausch Health Company Information
  129. 4.22.2 Bausch Health Business Overview
  130. 4.22.3 Bausch Health Congestive Heart Failure Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Bausch Health Congestive Heart Failure Drugs Product Portfolio
  132. 4.22.5 Bausch Health Recent Developments
5 Global Congestive Heart Failure Drugs Market Scenario by Region
  1. 5.1 Global Congestive Heart Failure Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Congestive Heart Failure Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Congestive Heart Failure Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Congestive Heart Failure Drugs Sales by Region: 2027-2032
  5. 5.3 Global Congestive Heart Failure Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Congestive Heart Failure Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Congestive Heart Failure Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Congestive Heart Failure Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Congestive Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Congestive Heart Failure Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Congestive Heart Failure Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Congestive Heart Failure Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Congestive Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Congestive Heart Failure Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Congestive Heart Failure Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Congestive Heart Failure Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Congestive Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Congestive Heart Failure Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Congestive Heart Failure Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Congestive Heart Failure Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Congestive Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Congestive Heart Failure Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Congestive Heart Failure Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Congestive Heart Failure Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Congestive Heart Failure Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Congestive Heart Failure Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Congestive Heart Failure Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Congestive Heart Failure Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Congestive Heart Failure Drugs Sales by Type (2021-2032) & (K Tons)
  3. 6.1.2 Global Congestive Heart Failure Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Congestive Heart Failure Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Congestive Heart Failure Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Congestive Heart Failure Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Congestive Heart Failure Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Congestive Heart Failure Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Congestive Heart Failure Drugs Sales by Application (2021-2032) & (K Tons)
  3. 7.1.2 Global Congestive Heart Failure Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Congestive Heart Failure Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Congestive Heart Failure Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Congestive Heart Failure Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Congestive Heart Failure Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Congestive Heart Failure Drugs Value Chain Analysis
  2. 8.1.1 Congestive Heart Failure Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Congestive Heart Failure Drugs Production Mode & Process
  5. 8.2 Congestive Heart Failure Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Congestive Heart Failure Drugs Distributors
  8. 8.2.3 Congestive Heart Failure Drugs Customers
9 Global Congestive Heart Failure Drugs Analyzing Market Dynamics
  1. 9.1 Congestive Heart Failure Drugs Industry Trends
  2. 9.2 Congestive Heart Failure Drugs Industry Drivers
  3. 9.3 Congestive Heart Failure Drugs Industry Opportunities and Challenges
  4. 9.4 Congestive Heart Failure Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst